S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial

Kintara Therapeutics (KTRA) Institutional Ownership

→ Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad)
Free KTRA Stock Alerts
$0.12
+0.01 (+13.88%)
(As of 04:37 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Kintara Therapeutics (NASDAQ:KTRA)

Current
Institutional Ownership
Percentage
0.62%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$37.63K
Number of
Institutional Sellers
(last 12 months)
0
Get KTRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kintara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

KTRA Institutional Buying and Selling by Quarter

Kintara Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2023Susquehanna International Group LLP10,662$39K0.0%N/A0.630%
2/15/2023Morgan Stanley4,252$29K0.0%+190.4%0.262%
2/15/2023Nantahala Capital Management LLC11,901$82K0.0%-98.0%0.735%
2/13/2023Geode Capital Management LLC14,134$97K0.0%-96.1%0.872%
11/15/2022Vanguard Group Inc.740,814$80K0.0%-47.7%45.842%
11/14/2022Renaissance Technologies LLC274,300$30K0.0%-62.0%0.339%
11/10/2022Nantahala Capital Management LLC594,813$64K0.0%+411.7%0.736%
8/15/2022Nantahala Capital Management LLC116,234$32K0.0%-82.5%0.177%
8/13/2022Renaissance Technologies LLC722,400$201K0.0%+1,210.7%1.102%
5/4/2022Advisor Group Holdings Inc.73,367$130K0.0%+182.7%0.150%
5/4/2022swisspartners Ltd.110,000$518K0.4%-60.0%0.224%
9/17/2021Virtu Financial LLC54,728$124K0.0%+30.9%0.168%
8/16/2021Nantahala Capital Management LLC523,279$1.19M0.0%-42.0%1.604%
8/16/2021State Street Corp107,974$245K0.0%+688.1%0.331%
8/13/2021Geode Capital Management LLC277,967$630K0.0%+82.8%0.852%
8/13/2021Vanguard Group Inc.1,122,231$2.55M0.0%+100.3%3.441%
8/12/2021Golden State Equity Partners71,320$162K0.1%N/A0.219%
5/21/2021Citadel Advisors LLC76,905$134K0.0%N/A0.236%
5/19/2021Virtu Financial LLC41,812$73K0.0%+144.6%0.129%
5/18/2021Citadel Advisors LLC76,905$134K0.0%N/A0.238%
5/14/2021Nantahala Capital Management LLC902,677$1.57M0.0%+230.7%2.788%
5/12/2021Northern Trust Corp44,142$77K0.0%+99.8%0.136%
5/12/2021Geode Capital Management LLC152,084$264K0.0%N/A0.470%
5/12/2021swisspartners Ltd.275,000$479K0.4%N/A0.849%
5/4/2021Envestnet Asset Management Inc.15,658$27K0.0%N/A0.048%
2/10/2021Renaissance Technologies LLC40,733$52K0.0%-76.3%0.165%
11/5/2020IPG Investment Advisors LLC26,000$36K0.0%N/A0.105%
8/7/2020Virtu Financial LLC68,359$47K0.0%N/A0.597%
(Data available from 1/1/2016 forward)

KTRA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of KTRA shares?

During the previous two years, the following institutional investors and hedge funds held shares of Kintara Therapeutics shares: swisspartners Ltd. ($518K), Advisor Group Holdings Inc. ($130K), Geode Capital Management LLC ($97K), Nantahala Capital Management LLC ($82K), Vanguard Group Inc. ($80K), Susquehanna International Group LLP ($39K), and Renaissance Technologies LLC ($30K).Learn more on KTRA's institutional investors.

What percentage of Kintara Therapeutics stock is owned by institutional investors?

0.62% of Kintara Therapeutics stock is owned by institutional investors. Learn more on KTRA's institutional investor holdings.

Which institutional investors have been buying Kintara Therapeutics stock?

The following institutional investors have purchased Kintara Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($667.28K), Nantahala Capital Management LLC ($478.58K), Advisor Group Holdings Inc. ($47.42K), Susquehanna International Group LLP ($10.66K), and Morgan Stanley ($2.79K).

How much institutional buying is happening at Kintara Therapeutics?

Institutional investors have bought a total of 1,206,728 shares in the last 24 months. This purchase volume represents approximately $12.86M in transactions.

Which Kintara Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Kintara Therapeutics stock in the last 24 months: Nantahala Capital Management LLC ($1.13M), Vanguard Group Inc. ($676.67K), Renaissance Technologies LLC ($448.10K), Geode Capital Management LLC ($343.89K), and swisspartners Ltd. ($165K).

How much institutional selling is happening at Kintara Therapeutics?

Institutional investors have sold a total of 2,763,617 shares in the last 24 months. This volume of shares sold represents approximately $23.35M in transactions.


Related Companies:
This page (NASDAQ:KTRA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative